HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chao-Long Chen Selected Research

Choledochal Cyst (Choledochal Cysts)

12/2010Endotoxin and CD14 in the progression of biliary atresia.
11/2008Upstream stimulatory factor 2 is implicated in the progression of biliary atresia by regulation of hepcidin expression.
7/2008Evaluation of hepatocyte growth factor in patients with biliary atresia.
9/2007Early stage of biliary atresia is associated with significant changes in 8-hydroxydeoxyguanosine and mitochondrial copy number.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chao-Long Chen Research Topics

Disease

41Hepatocellular Carcinoma (Hepatoma)
03/2022 - 02/2003
30Neoplasms (Cancer)
02/2022 - 09/2002
28Biliary Atresia
10/2021 - 02/2004
14End Stage Liver Disease
10/2021 - 03/2003
13Liver Cirrhosis (Hepatic Cirrhosis)
01/2020 - 02/2004
13Fibrosis (Cirrhosis)
02/2016 - 02/2003
12Infections
10/2022 - 12/2002
11Hemorrhage
03/2021 - 09/2005
10Liver Neoplasms (Liver Cancer)
01/2022 - 03/2003
9Inflammation (Inflammations)
01/2021 - 03/2004
8Hepatitis B
02/2022 - 12/2002
7Thrombosis (Thrombus)
09/2020 - 04/2004
6Hepatitis
01/2022 - 12/2007
6Fatty Liver
12/2018 - 08/2011
5Ascites
02/2019 - 07/2003
5Body Weight (Weight, Body)
06/2015 - 07/2003
4Liver Diseases (Liver Disease)
07/2022 - 06/2013
4Sepsis (Septicemia)
02/2022 - 06/2008
4Wounds and Injuries (Trauma)
01/2016 - 11/2002
4Hepatic Encephalopathy
11/2015 - 12/2007
4Choledochal Cyst (Choledochal Cysts)
12/2010 - 09/2007
4Cholestasis
10/2009 - 06/2004
3Liver Failure
01/2022 - 09/2015
3Non-alcoholic Fatty Liver Disease
12/2021 - 08/2011
3Disease Progression
01/2020 - 12/2007
3Portal Hypertension
02/2019 - 12/2005
3Esophageal and Gastric Varices (Esophageal Varices)
02/2019 - 09/2005
3Jaundice (Icterus)
02/2019 - 12/2010
3Anemia
07/2014 - 05/2004
3Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2011 - 03/2005
2Acute Kidney Injury (Acute Renal Failure)
05/2022 - 07/2020
2Chronic Renal Insufficiency
05/2022 - 04/2017
2Cardiovascular Diseases (Cardiovascular Disease)
05/2022 - 02/2015
2Chronic Kidney Failure (Chronic Renal Failure)
05/2022 - 04/2017
2Tuberculosis (Tuberculoses)
12/2021 - 10/2018
2Acute-On-Chronic Liver Failure
11/2021 - 01/2013
2Glycogen Storage Disease (Glycogenosis)
10/2021 - 06/2005
2Diabetes Mellitus
07/2020 - 06/2018
2Pathologic Constriction (Stenosis)
07/2020 - 11/2006
2Hyponatremia
07/2020 - 11/2014
2Chronic Hepatitis C
01/2020 - 01/2018
2Splenomegaly
02/2019 - 01/2010
2Renal Insufficiency (Renal Failure)
01/2019 - 04/2017
2Acute Lung Injury
11/2018 - 06/2014

Drug/Important Bio-Agent (IBA)

7alpha-Fetoproteins (alpha-Fetoprotein)IBA
02/2022 - 01/2008
7Pharmaceutical PreparationsIBA
12/2021 - 03/2002
7EnzymesIBA
11/2018 - 01/2006
6CytokinesIBA
01/2018 - 12/2002
6Proteins (Proteins, Gene)FDA Link
08/2011 - 02/2004
6Messenger RNA (mRNA)IBA
10/2009 - 05/2004
4CreatinineIBA
10/2021 - 01/2018
4Glucose (Dextrose)FDA LinkGeneric
10/2021 - 05/2005
4Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2015
4Anesthetics (Anesthetic Agents)IBA
07/2020 - 06/2004
4Antiviral Agents (Antivirals)IBA
01/2020 - 04/2014
4ImmunosorbentsIBA
12/2010 - 07/2008
3Cholecalciferol (Vitamin D3)FDA Link
10/2021 - 08/2011
3Hemoglobins (Hemoglobin)IBA
01/2021 - 06/2004
3BilirubinIBA
02/2019 - 12/2007
3LipopolysaccharidesIBA
11/2018 - 10/2009
3Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2018 - 07/2009
3AntioxidantsIBA
11/2017 - 01/2015
3Sorafenib (BAY 43-9006)FDA Link
06/2015 - 06/2013
3Hepatitis B Surface Antigens (HBsAg)FDA Link
04/2014 - 02/2003
3AlbuminsIBA
12/2012 - 07/2003
3Transforming Growth Factor beta (TGF-beta)IBA
01/2010 - 05/2004
3Transforming Growth Factor beta1 (TGF beta 1)IBA
01/2010 - 05/2004
3HepcidinsIBA
10/2009 - 05/2006
2Anti-Bacterial Agents (Antibiotics)IBA
02/2022 - 01/2013
2Biological ProductsIBA
02/2022 - 02/2020
2entecavirFDA Link
01/2022 - 04/2014
2Immunosuppressive Agents (Immunosuppressants)IBA
12/2021 - 09/2015
2GlycogenIBA
10/2021 - 06/2007
2Doxorubicin (Adriamycin)FDA LinkGeneric
11/2020 - 01/2020
2Blood Glucose (Blood Sugar)IBA
07/2020 - 06/2005
2Triglycerides (Triacylglycerol)IBA
01/2020 - 06/2018
2LipidsIBA
01/2020 - 08/2011
2Choline (Choline Chloride)IBA
01/2020 - 08/2011
2Ethiodized Oil (Ethiodol)FDA Link
02/2019 - 10/2018
2EnbucrilateIBA
02/2019 - 03/2011
2Sirolimus (Rapamycin)FDA Link
01/2019 - 04/2017
2EverolimusFDA Link
01/2019 - 07/2014
2hydroxide ionIBA
12/2018 - 01/2018
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
12/2018 - 11/2010

Therapy/Procedure

111Liver Transplantation
10/2022 - 11/2002
13Hepatectomy
01/2022 - 01/2003
13Therapeutics
12/2021 - 12/2002
11Transplantation
10/2022 - 03/2005
6Anesthesia
06/2015 - 11/2002
6Blood Transfusion (Blood Transfusions)
08/2010 - 07/2003
5Length of Stay
01/2016 - 07/2007
4Phototherapy (Light Therapy)
10/2021 - 08/2011
4Ligation
02/2019 - 12/2007
4Hepatic Portoenterostomy
06/2018 - 07/2008
3Laparotomy
01/2018 - 02/2009
3Operative Time
02/2016 - 08/2010
3Splenectomy
07/2012 - 09/2005
2Aftercare (After-Treatment)
11/2020 - 01/2020
2Contraindications
09/2019 - 02/2017
2Sclerotherapy
02/2019 - 08/2018